Hong Kong stocks fell collectively in the concept of innovative drugs, and Sansei Pharmaceuticals fell more than 7%.

Hong Kong stocks' concept of innovative drugs collectively fell, with Sanfo Pharmaceutical falling more than 7%, Kingsway Biotechnology, Tasly Pharmaceutical Group, and GalaPharma all following suit.